Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience
Objective To examine real-world treatment persistence, colectomy-free survival and treatment switching patterns in UK patients with ulcerative colitis (UC) prescribed golimumab or adalimumab.Design This was a retrospective chart review study in adult patients diagnosed with UC using data from 16 Nat...
Saved in:
| Main Authors: | Sami Hoque, Christopher M Black, Amy Puenpatom, Simona Boccaletti, Chloe Green, Jenna Roberts, Ivana Rajkovic, Gary Milligan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000476.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease
by: María Calvo-Arbeloa, et al.
Published: (2020-03-01) -
Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
by: Federica Rivolta, et al.
Published: (2023-03-01) -
Golimumab-induced lichen planus pigmentosus in a patient with ulcerative colitis
by: Daniela Alfaro-Sepúlveda, et al.
Published: (2025-08-01) -
Clostridium difficile Enteritis after Total Abdominal Colectomy for Ulcerative Colitis
by: Hassan Nasser, et al.
Published: (2019-01-01) -
GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
by: G. V. Lukina, et al.
Published: (2015-04-01)